NCT03163641 is a NA clinical trial of Acuvue Oasys in Corneal Epithelial Wound, sponsored by Eyegate Pharmaceuticals, Inc..

Who is sponsoring NCT03163641?

NCT03163641 is sponsored by Eyegate Pharmaceuticals, Inc..

What drugs are being tested in NCT03163641?

Interventions in NCT03163641: Acuvue Oasys, Ocular Bandage Gel.

What condition does NCT03163641 study?

NCT03163641 studies Corneal Epithelial Wound.

Is NCT03163641 still recruiting?

NCT03163641 is currently completed. Last updated 17 December 2020.

Last reviewed 2020-12-17 · How we verify

NCT03163641

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety and Effectiveness of OBG vs.a Bandage Contact Lens for Large Corneal Epithelial Defects in Patients Post-PRK.

Completed NA Last updated 17 December 2020

What this trial tests

NA trial testing Acuvue Oasys in Corneal Epithelial Wound in 45 participants. Completed in 8 November 2018.

Timeline

5 August 2018

Primary endpoint
31 October 2018

8 November 2018

Quick facts

Lead sponsor	Eyegate Pharmaceuticals, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	45
Start date	5 August 2018
Primary completion	31 October 2018
Estimated completion	8 November 2018
Sites	1 location across United States

Drugs / interventions tested

Acuvue Oasys
Ocular Bandage Gel

Conditions studied

Corneal Epithelial Wound — all drugs for Corneal Epithelial Wound →

Sponsor

Eyegate Pharmaceuticals, Inc. — full company profile →

Who can join

Adults 22 to 50, any sex, with Corneal Epithelial Wound. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, randomized (Reading Center), masked, controlled study in up to 45 subjects who have undergone bilateral PRK with epithelial removal using alcohol in a 9.0 mm well or trephine at the time of surgery to ensure consistency of the size of the ablation area.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Acuvue Oasys

Trials testing the same drug.

NCT03209505 — The Impact of Contact Lens Coefficient of Friction (CoF) on the Development of Lid Wiper Epitheliopathy (LWE) · Phase 4 · completed

Other Eyegate Pharmaceuticals, Inc. trials

Trials by the same sponsor.

NCT03938883 — Ocular Bandage Gel (OBG) Pivotal Trial in Patients Undergoing Photorefractive Keratectomy ("PRK") · NA · completed
NCT03180255 — Iontophoretic Delivery of EGP-437 in Patients Who Have Undergone Cataract Surgery · Phase 2 · completed
NCT02517619 — Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis · Phase 3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03163641 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Eyegate Pharmaceuticals, Inc.
Last refreshed: 17 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03163641.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing